<!DOCTYPE html> <html lang = "en">
 <body>

<h2>Pubmed_ID: 33328653</h2>

<h3>Coinfection and infection duration shape how pathogens affect the African buffalo gut microbiota</h3>

<h3>合并感染和感染持续时间决定了病原体如何影响非洲水牛肠道菌群 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41396-020-00855-0</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33328653/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: The ISME journal   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/17/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Changes in the gut microbiota during pathogen infection are often predicted to influence disease outcomes. However, studies exploring whether pathogens induce microbiota shifts have yielded inconsistent results. This suggests that variation in infection, rather than the presence of infection alone, might shape pathogen-microbiota relationships. For example, most hosts are coinfected with multiple pathogens simultaneously, and hosts vary in how long they are infected, which may amplify or diminish microbial shifts expected in response to a focal pathogen. We used a longitudinal anthelmintic treatment study of free-ranging African buffalo (Syncerus caffer) to examine whether (i) coinfection with bovine tuberculosis (Mycobacterium bovis, TB) and gastrointestinal nematodes, and (ii) the duration of TB infection, modified effects of single pathogens on the gut microbiota. By accounting for the interaction between TB and nematodes, we found that coinfection affected changes in microbial abundance associated with single infections. Furthermore, the duration of TB infection predicted more microbiota variation than the presence of TB. Importantly, coinfection and infection duration had nearly as much influence on microbial patterns as demographic and environmental factors commonly examined in microbiota research. These findings demonstrate that acknowledging infection heterogeneities may be crucial to understanding relationships between pathogens and the gut microbiota.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 通常预计病原体感染期间肠道菌群的变化会影响疾病的预后。然而，探索病原体是否引起微生物群转移的研究产生了不一致的结果。这表明感染的变化，而不是单独存在的感染，可能会影响病原体与微生物群的关系。例如，大多数宿主会同时感染多种病原体，宿主的感染时间会有所不同，这可能会放大或减少对病原体的预期微生物迁移。我们使用了自由放养的非洲水牛（Synceruscaffer）的纵向驱虫治疗研究，以检查（i）合并感染牛结核病（牛分枝杆菌（Mycobacteriumbovis，TB））和胃肠道线虫，以及（ii）结核病感染的持续时间，肠道菌群上的单一病原体。通过考虑结核病和线虫之间的相互作用，我们发现合并感染影响与单一感染相关的微生物丰度变化。此外，结核病感染的持续时间比结核病的存在预示着更多的微生物群变异。重要的是，合并感染和感染持续时间对微生物模式的影响与微生物群研究中通常检查的人口统计和环境因素几乎一样大。这些发现表明，认识感染的异质性对于理解病原体和肠道菌群之间的关系可能至关重要。</p>

<h2>Pubmed_ID: 33328643</h2>

<h3>Video: A healthy bacterial balance</h3>

<h3>视频：健康的细菌平衡 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/d41586-020-03578-6</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33328643/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Nature  {'ISSN': '0028-0836', 'Name': 'nature', '2019': '42.779', '2018': '43.07', '2017': '41.577', '2016': '40.137', '2015': '38.138'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/16/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: No abstract</p>

<p style="line-height:1.8;margin:20px"> 摘要: 没有摘要</p>

<h2>Pubmed_ID: 33328245</h2>

<h3>Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis</h3>

<h3>早产儿的人乳低聚糖DSLNT和肠道微生物组可预测坏死性小肠结肠炎 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2020-322771</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33328245/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/16/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Objective: Necrotising enterocolitis (NEC) is a devastating intestinal disease primarily affecting preterm infants. The underlying mechanisms are poorly understood: mother's own breast milk (MOM) is protective, possibly relating to human milk oligosaccharide (HMO) and infant gut microbiome interplay. We investigated the interaction between HMO profiles and infant gut microbiome development and its association with NEC. Design: We performed HMO profiling of MOM in a large cohort of infants with NEC (n=33) with matched controls (n=37). In a subset of 48 infants (14 with NEC), we also performed longitudinal metagenomic sequencing of infant stool (n=644). Results: Concentration of a single HMO, disialyllacto-N-tetraose (DSLNT), was significantly lower in MOM received by infants with NEC compared with controls. A MOM threshold level of 241 nmol/mL had a sensitivity and specificity of 0.9 for NEC. Metagenomic sequencing before NEC onset showed significantly lower relative abundance of Bifidobacterium longum and higher relative abundance of Enterobacter cloacae in infants with NEC. Longitudinal development of the microbiome was also impacted by low MOM DSLNT associated with reduced transition into preterm gut community types dominated by Bifidobacterium spp and typically observed in older infants. Random forest analysis combining HMO and metagenome data before disease accurately classified 87.5% of infants as healthy or having NEC. Conclusion: These results demonstrate the importance of HMOs and gut microbiome in preterm infant health and disease. The findings offer potential targets for biomarker development, disease risk stratification and novel avenues for supplements that may prevent life-threatening disease.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 目的：坏死性小肠结肠炎（NEC）是一种破坏性肠道疾病，主要影响早产儿。人们对潜在的机制了解甚少：母亲自己的母乳（MOM）具有保护作用，可能与人乳寡糖（HMO）和婴儿肠道微生物组之间的相互作用有关。我们调查了HMO概况和婴儿肠道微生物组发展及其与NEC之间的相互作用。设计：我们在一个大队列的NEC婴儿（n=33）和匹配的对照组（n=37）中对MOM进行了HMO分析。在48名婴儿（其中14名患有NEC）中，我们还对婴儿粪便进行了纵向宏基因组测序（n=644）。结果：与对照组相比，NEC婴儿接受的MOM中单一HMO的二唾液酸内酯N-四糖（DSLNT）浓度显着降低。MOM阈值水平为241nmol/mL，对NEC的敏感性和特异性为0.9。NEC发生前的基因组测序表明，NEC婴儿的长双歧杆菌相对丰度明显降低，而阴沟肠杆菌相对丰度更高。微生物组的纵向发展还受到低MOMDSLNT的影响，这与过渡到以双歧杆菌属为主的早产肠道群落类型减少有关，通常在年龄较大的婴儿中观察到。疾病发生前结合HMO和元基因组数据进行的随机森林分析将87.5％的婴儿准确分类为健康或患有NEC。结论：这些结果证明了HMO和肠道微生物组在早产儿健康和疾病中的重要性。这些发现为生物标志物的开发，疾病风险分层以及可能预防威胁生命的疾病的补充剂提供了新的途径。</p>

<h2>Pubmed_ID: 33323978</h2>

<h3>Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels</h3>

<h3>代谢建模预测特定的肠道细菌是白色念珠菌定植水平的关键决定因素 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41396-020-00848-z</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33323978/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: The ISME journal   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/15/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Candida albicans is a leading cause of life-threatening hospital-acquired infections and can lead to Candidemia with sepsis-like symptoms and high mortality rates. We reconstructed a genome-scale C. albicans metabolic model to investigate bacterial-fungal metabolic interactions in the gut as determinants of fungal abundance. We optimized the predictive capacity of our model using wild type and mutant C. albicans growth data and used it for in silico metabolic interaction predictions. Our analysis of more than 900 paired fungal-bacterial metabolic models predicted key gut bacterial species modulating C. albicans colonization levels. Among the studied microbes, Alistipes putredinis was predicted to negatively affect C. albicans levels. We confirmed these findings by metagenomic sequencing of stool samples from 24 human subjects and by fungal growth experiments in bacterial spent media. Furthermore, our pairwise simulations guided us to specific metabolites with promoting or inhibitory effect to the fungus when exposed in defined media under carbon and nitrogen limitation. Our study demonstrates that in silico metabolic prediction can lead to the identification of gut microbiome features that can significantly affect potentially harmful levels of C. albicans.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 白色念珠菌是威胁生命的医院获得性感染的主要原因，可导致带有败血症样症状和高死亡率的念珠菌血症。我们重建了一个基因组规模的白色念珠菌代谢模型，以研究肠道中细菌-真菌的代谢相互作用，作为真菌丰度的决定因素。我们使用野生型和突变白色念珠菌生长数据优化了模型的预测能力，并将其用于计算机代谢代谢预测。我们对900多个配对的真菌-细菌代谢模型的分析预测了调节白念珠菌定居水平的关键肠道细菌物种。在研究的微生物中，预计腐臭菌会对白色念珠菌水平产生负面影响。我们通过对来自24位人类受试者的粪便样本进行宏基因组测序，以及在细菌用过的培养基中进行真菌生长实验，证实了这些发现。此外，当在碳和氮限制下暴露于确定的培养基中时，我们的成对模拟将我们引导至对真菌具有促进或抑制作用的特定代谢产物。我们的研究表明，计算机代谢预测可以导致识别肠道微生物组特征，从而显着影响白色念珠菌的潜在有害水平。</p>

<h2>Pubmed_ID: 33319778</h2>

<h3>A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity</h3>

<h3>猪肠道细菌分离株的集合揭示了功能和分类学上的多样性 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41467-020-19929-w</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33319778/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Nature communications  {'ISSN': '2041-1723', 'Name': 'nature communications', '2019': '12.121', '2018': '11.878', '2017': '12.353', '2016': '12.124', '2015': '11.329'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/15/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Our knowledge about the gut microbiota of pigs is still scarce, despite the importance of these animals for biomedical research and agriculture. Here, we present a collection of cultured bacteria from the pig gut, including 110 species across 40 families and nine phyla. We provide taxonomic descriptions for 22 novel species and 16 genera. Meta-analysis of 16S rRNA amplicon sequence data and metagenome-assembled genomes reveal prevalent and pig-specific species within Lactobacillus, Streptococcus, Clostridium, Desulfovibrio, Enterococcus, Fusobacterium, and several new genera described in this study. Potentially interesting functions discovered in these organisms include a fucosyltransferase encoded in the genome of the novel species Clostridium porci, and prevalent gene clusters for biosynthesis of sactipeptide-like peptides. Many strains deconjugate primary bile acids in in vitro assays, and a Clostridium scindens strain produces secondary bile acids via dehydroxylation. In addition, cells of the novel species Bullifex porci are coccoidal or spherical under the culture conditions tested, in contrast with the usual helical shape of other members of the family Spirochaetaceae. The strain collection, called 'Pig intestinal bacterial collection' (PiBAC), is publicly available at www.dsmz.de/pibac and opens new avenues for functional studies of the pig gut microbiota.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管这些动物对于生物医学研究和农业很重要，但我们对猪肠道菌群的了解仍然很少。在这里，我们介绍了来自猪肠道的细菌培养物，包括40个科的110种和9个门。我们提供了22个新物种和16属的分类学描述。对16SrRNA扩增子序列数据和元基因组组装的基因组的荟萃分析揭示了乳杆菌，链球菌，梭菌，脱硫弧菌，肠球菌，梭菌和本研究中描述的几个新属中普遍存在的猪特异性物种。在这些生物中发现的潜在有趣功能包括在新型物种梭状芽胞杆菌基因组中编码的岩藻糖基转移酶，以及用于生物合成类肽肽的普遍基因簇。在体外测定中，许多菌株使伯胆汁酸解偶联，梭菌梭状芽胞杆菌菌株通过脱羟基产生仲胆汁酸。此外，与螺旋藻科其他成员通常的螺旋形相比，在测试的培养条件下，新型种Bullifexporci的细胞呈球形或球形。该品系被称为“猪肠道细菌菌种”（PiBAC），可在www.dsmz.de/pibac上公开获得，为猪肠道菌群的功能研究开辟了新途径。</p>

<h2>Pubmed_ID: 33319645</h2>

<h3>Microbial enterotypes beyond genus level: Bacteroides species as a predictive biomarker for weight change upon controlled intervention with arabinoxylan oligosaccharides in overweight subjects</h3>

<h3>超出属水平的微生物肠型：在超重受试者中，阿拉伯糖木聚糖寡糖的受控干预下，拟杆菌属作为体重变化的预测生物标志物 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1847627</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33319645/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2019': '7.74', '2018': '7.823', '2017': '0', '2016': '0', '2015': '0'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/15/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Recent studies indicate that microbial enterotypes may influence the beneficial effects of wholegrain enriched diets including bodyweight regulation. In a 4-week intervention trial, overweight subjects were randomized to consume either arabinoxylan-oligosaccharides (AXOS) (10.4 g/d) from wheat bran or polyunsaturated fatty acids (PUFA) (3.6 g/d). In the present study, we have stratified the subjects participating in the intervention (n = 29) according to the baseline Prevotella-to-Bacteroides (P/B) ratios through a post-hoc analysis and applied a linear mixed model analysis to identify the influence of this P/B ratio on the differences in weight changes in the intervention arms. Following AXOS consumption (n = 15), the high P/B group showed no bodyweight changes [-0.14 kg (95% CI: -0.67; 0.38, p = .59)], while the low P/B group gained 0.65 kg (95% CI: 0.16; 1.14, p = .009). Consequently, a difference of -0.79 kg was found between P/B groups (95% CI: -1.51; -0.08, p = .030). No differences were found between P/B groups following PUFA consumption (0.61 kg, 95% CI: -0.13; 1.35, p = .10). Among the Bacteroides species, B. cellulosilyticus relative abundance exhibited the highest positive rank correlation (Kendall's tau = 0.51, FDR p = .070) with 4-week weight change on AXOS, and such association was further supported by using supervised classification methods (Random Forest). We outlined several carbohydrate-active enzyme (CAZy) genes involved in xylan-binding and degradation to be enriched in B. cellulosilyticus genomes, as well as multiple accessory genes, suggesting a supreme AXOS-derived glycan scavenging role of such species. This post-hoc analysis, ensuring species and strain demarcation at the human gut microbiota, permitted to uncover the predictive role of Bacteroides species over P/B enterotype in weight gain during a fiber-based intervention. The results of this pilot trial pave the way for future assessments on fiber fermentation outputs from Bacteroides species affecting lipid metabolism in the host and with direct impact on adiposity, thus helping to design personalized interventions.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 最近的研究表明，微生物的肠型可能会影响全麦饮食（包括体重调节）的有益作用。在一项为期4周的干预试验中，超重受试者被随机摄入麦麸中的阿拉伯木聚糖寡糖（AXOS）（10.4g/d）或多不饱和脂肪酸（PUFA）（3.6g/d）。在本研究中，我们通过事后分析根据基线普氏杆菌与拟杆菌（P/B）的比率对参与干预的受试者（n=29）进行了分层，并应用了线性混合模型分析来确定P/B比对干预组体重变化差异的影响。服用AXOS（n=15）后，高P/B组体重没有变化[-0.14kg（95％CI：-0.67;0.38，p=.59）]，而低P/B组体重增加了0.65kg（95％CI：0.16；1.14，p=.009）。因此，P/B组之间的差异为-0.79千克（95％CI：-1.51；-0.08，p=.030）。食用PUFA后，P/B组之间未发现差异（0.61kg，95％CI：-0.13；1.35，p=.10）。在拟杆菌属中，溶纤芽孢杆菌相对丰度表现出最高的正等级相关性（Kendallstau=0.51，FDRp=.070），并且在AXOS上有4周的体重变化，这种关联得到了有监督分类方法的进一步支持（Random森林）。我们概述了涉及木聚糖结合和降解的几个碳水化合物活性酶（CAZy）基因，以丰富在B.cellulosilyticus基因组中，以及多个辅助基因，表明此类物种具有最高的AXOS衍生的聚糖清除作用。这项事后分析确保了人类肠道菌群的物种和菌株分界，从而揭示了基于纤维的干预过程中，拟杆菌属物种相对于P/B肠型在体重增加中的预测作用。该试验性试验的结果为将来评估拟杆菌属细菌纤维发酵产物的方法铺平了道路，这些细菌影响宿主中的脂质代谢并直接影响肥胖，因此有助于设计个性化干预措施。</p>

<h2>Pubmed_ID: 33318144</h2>

<h3>F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer</h3>

<h3>F. nucleatum靶向lncRNA ENO1-IT1促进结直肠癌的糖酵解和肿瘤发生 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2020-322780</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33318144/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/14/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Objective: Microbiota disorder promotes chronic inflammation and carcinogenesis. High glycolysis is associated with poor prognosis in patients with colorectal cancer (CRC). However, the potential correlation between the gut microbiota and glucose metabolism is unknown in CRC. Design: 18F-FDG (18F-fluorodeoxyglucose) PET (positron emission tomography)/CT image scanning data and microbiota PCR analysis were performed to measure the correlation between metabolic alterations and microbiota disorder in 33 patients with CRC. Multiple colorectal cancer models, metabolic analysis and Seahorse assay were established to assess the role of long non-coding RNA (lncRNA) enolase1-intronic transcript 1 (ENO1-IT1) in Fusobacterium (F.) nucleatum-induced glucose metabolism and colorectal carcinogenesis. RNA immunoprecipitation and chromatin immunoprecipitation sequencing were conducted to identify potential targets of lncRNA ENO1-IT1. Results: We have found F. nucleatum abundance correlated with high glucose metabolism in patients with CRC. Furthermore, F. nucleatum supported carcinogenesis via increasing CRC cell glucose metabolism. Mechanistically, F. nucleatum activated lncRNA ENO1-IT1 transcription via upregulating the binding efficiency of transcription factor SP1 to the promoter region of lncRNA ENO1-IT1. Elevated ENO1-IT behaved as a guider modular for KAT7 histone acetyltransferase, specifying the histone modification pattern on its target genes, including ENO1, and consequently altering CRC biological function. Conclusion: F. nucleatum and glucose metabolism are mechanistically, biologically and clinically connected to CRC. Targeting ENO1 pathway may be meaningful in treating patients with CRC with elevated F. nucleatum.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 目的：微生物群疾病促进慢性炎症和致癌作用。高糖酵解与大肠癌（CRC）患者的预后不良有关。然而，在CRC中，肠道菌群与葡萄糖代谢之间的潜在相关性尚不清楚。设计：对33例CRC患者进行18F-FDG（18F-氟脱氧葡萄糖）PET（正电子发射断层扫描）/CT图像扫描数据和微生物群PCR分析，以测量代谢改变与微生物群失调之间的相关性。建立了多种结直肠癌模型，代谢分析和Seahorse分析，以评估长非编码RNA（lncRNA）烯醇化酶1-内含子转录本1（ENO1-IT1）在Fusobacter（F.）核诱导葡萄糖代谢和结直肠癌发生中的作用。进行了RNA免疫沉淀和染色质免疫沉淀测序，以鉴定lncRNAENO1-IT1的潜在靶标。结果：我们发现CRC患者的核糖核酸丰度与高糖代谢相关。此外，F。nucleatum通过增加CRC细胞葡萄糖代谢来支持癌变。从机制上讲，核仁镰刀菌通过上调转录因子SP1与lncRNAENO1-IT1启动子区域的结合效率来激活lncRNAENO1-IT1转录。升高的ENO1-IT充当KAT7组蛋白乙酰转移酶的指导模块，在其靶基因（包括ENO1）上指定组蛋白修饰模式，从而改变CRC生物学功能。结论：核仁和葡萄糖代谢在机制，生物学和临床上均与CRC有关。靶向ENO1途径在治疗核仁镰刀菌升高的CRC患者中可能有意义。</p>

<h2>Pubmed_ID: 33257580</h2>

<h3>A thermogenic fat-epithelium cell axis regulates intestinal disease tolerance</h3>

<h3>产热脂肪上皮细胞轴调节肠道疾病的耐受性 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1073/pnas.2012003117</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33257580/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Proceedings of the National Academy of Sciences of the United States of America  {'ISSN': '0027-8424', 'Name': 'proceedings of the national academy of sciences of the united states of america', '2019': '9.412', '2018': '9.58', '2017': '9.504', '2016': '9.661', '2015': '9.423'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 12/15/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Disease tolerance, the capacity of tissues to withstand damage caused by a stimulus without a decline in host fitness, varies across tissues, environmental conditions, and physiologic states. While disease tolerance is a known strategy of host defense, its role in noninfectious diseases has been understudied. Here, we provide evidence that a thermogenic fat-epithelial cell axis regulates intestinal disease tolerance during experimental colitis. We find that intestinal disease tolerance is a metabolically expensive trait, whose expression is restricted to thermoneutral mice and is not transferable by the microbiota. Instead, disease tolerance is dependent on the adrenergic state of thermogenic adipocytes, which indirectly regulate tolerogenic responses in intestinal epithelial cells. Our work has identified an unexpected mechanism that controls intestinal disease tolerance with implications for colitogenic diseases.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 疾病耐受性（组织承受刺激引起的损害的能力而不会降低宿主适应性）随组织，环境条件和生理状态的不同而变化。虽然疾病耐受性是宿主防御的已知策略，但其在非传染性疾病中的作用已被研究不足。在这里，我们提供的证据表明，在实验性结肠炎期间，产热脂肪上皮细胞轴可调节肠道疾病的耐受性。我们发现肠道疾病的耐受性是一项代谢昂贵的性状，其表达仅限于热中性小鼠，不能被微生物群转移。取而代之的是，疾病的耐受性取决于产热的脂肪细胞的肾上腺素能状态，后者间接调节肠上皮细胞的致耐受性反应。我们的工作已经确定了一种意想不到的机制，该机制可控制肠道疾病的耐受性并影响大肠埃希菌病。</p>

<h2>Pubmed_ID: 33239339</h2>

<h3>Autologous faecal microbiota transplantation for type 1 diabetes: a potential mindshift in therapeutic microbiome manipulation?</h3>

<h3>自体粪便微生物群移植治疗1型糖尿病：治疗性微生物组操作中的潜在思维转变？ </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2020-323252</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33239339/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2021 Jan</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: No abstract</p>

<p style="line-height:1.8;margin:20px"> 摘要: 没有摘要</p>

<h2>Pubmed_ID: 33106354</h2>

<h3>Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial</h3>

<h3>粪便微生物群移植在一项随机对照试验中阻止了人类新发1型糖尿病的进展 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2020-322630</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33106354/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2021 Jan</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Objective: Type 1 diabetes (T1D) is characterised by islet autoimmunity and beta cell destruction. A gut microbiota-immunological interplay is involved in the pathophysiology of T1D. We studied microbiota-mediated effects on disease progression in patients with type 1 diabetes using faecal microbiota transplantation (FMT). Design: Patients with recent-onset (<6 weeks) T1D (18-30 years of age) were randomised into two groups to receive three autologous or allogenic (healthy donor) FMTs over a period of 4 months. Our primary endpoint was preservation of stimulated C peptide release assessed by mixed-meal tests during 12 months. Secondary outcome parameters were changes in glycaemic control, fasting plasma metabolites, T cell autoimmunity, small intestinal gene expression profile and intestinal microbiota composition. Results: Stimulated C peptide levels were significantly preserved in the autologous FMT group (n=10 subjects) compared with healthy donor FMT group (n=10 subjects) at 12 months. Small intestinal Prevotella was inversely related to residual beta cell function (r=-0.55, p=0.02), whereas plasma metabolites 1-arachidonoyl-GPC and 1-myristoyl-2-arachidonoyl-GPC levels linearly correlated with residual beta cell preservation (rho=0.56, p=0.01 and rho=0.46, p=0.042, respectively). Finally, baseline CD4 +CXCR3+T cell counts, levels of small intestinal Desulfovibrio piger and CCL22 and CCL5 gene expression in duodenal biopsies predicted preserved beta cell function following FMT irrespective of donor characteristics. Conclusion: FMT halts decline in endogenous insulin production in recently diagnosed patients with T1D in 12 months after disease onset. Several microbiota-derived plasma metabolites and bacterial strains were linked to preserved residual beta cell function. This study provides insight into the role of the intestinal gut microbiome in T1D. Trial registration number: NTR3697.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 目的：1型糖尿病（T1D）的特征是胰岛自身免疫和β细胞破坏。肠道微生物与免疫的相互作用与T1D的病理生理有关。我们使用粪便微生物群移植（FMT）研究了微生物群介导的对1型糖尿病患者疾病进展的影响。设计：将新近发病（<6周）T1D（18-30岁）的患者随机分为两组，在4个月内接受三个自体或异体（健康供体）FMT。我们的主要终点是在12个月内通过混合膳食测试评估保留受刺激的C肽释放。次要结果参数是血糖控制，空腹血浆代谢物，T细胞自身免疫性，小肠基因表达谱和肠道菌群组成的变化。结果：与健康供体FMT组（n=10个受试者）相比，自体FMT组（n=10个受试者）在12个月时C肽水平得到了显着的保护。小肠Prevotella与残留的β细胞功能成反比（r=-0.55，p=0.02），而血浆代谢产物1-花生四烯酸-GPC和1-肉豆蔻酰基-2-花生四烯酸-GPC的水平与残留β细胞的保存呈线性相关（rho=0.56，p=0.01，rho=0.46，p=0.042）。最后，十二指肠活检中的基线CD4+CXCR3+T细胞计数，小肠脱硫弧菌的水平以及CCL22和CCL5基因的表达预测了FMT后保留的β细胞功能，无论供体特征如何。结论：在发病后的12个月内，FMT阻止了新近诊断的T1D患者的内源性胰岛素产生下降。几种微生物来源的血浆代谢物和细菌菌株与保留的残留β细胞功能有关。这项研究提供了肠道肠道微生物组在T1D中的作用的见解。试用注册号：NTR3697。</p>

<h2>Pubmed_ID: 32317331</h2>

<h3>Identifying the factors influencing outcome in probiotic studies in overweight and obese patients: host or microbiome?</h3>

<h3>在超重和肥胖患者中鉴定影响益生菌研究结果的因素：宿主还是微生物组？ </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2020-321110</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32317331/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2021 Jan</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: No abstract</p>

<p style="line-height:1.8;margin:20px"> 摘要: 没有摘要</p>

<h2>Pubmed_ID: 32303608</h2>

<h3>Improvement in sperm quality and spermatogenesis following faecal microbiota transplantation from alginate oligosaccharide dosed mice</h3>

<h3>藻酸盐寡糖定剂量小鼠粪便菌群移植后精子质量和精子发生的改善 </h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2020-320992</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32303608/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2021 Jan</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: No abstract</p>

<p style="line-height:1.8;margin:20px"> 摘要: 没有摘要</p>

</body>
</html>

